These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9109744)
1. Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. Specht U; May TW; Rohde M; Wagner V; Schmidt RC; Schütz M; Wolf P Arch Neurol; 1997 Apr; 54(4):427-31. PubMed ID: 9109744 [TBL] [Abstract][Full Text] [Related]
2. Cerebellar atrophy does not increase susceptibility to carbamazepine toxicity. Specht U; Rohde M; May T; Schmidt RC; Meencke HJ; Wolf P Acta Neurol Scand; 1994 Jan; 89(1):1-4. PubMed ID: 8178620 [TBL] [Abstract][Full Text] [Related]
4. [Cerebellar atrophy and phenytoin poisoning. An MR study]. Luef G; Marosi M; Felber S; Birbamer G; Aichner F; Bauer G Nervenarzt; 1993 Aug; 64(8):548-51. PubMed ID: 8413755 [TBL] [Abstract][Full Text] [Related]
5. Measuring the effects of antiepileptic medications on balance in older people. Fife TD; Blum D; Fisher RS Epilepsy Res; 2006 Aug; 70(2-3):103-9. PubMed ID: 16675199 [TBL] [Abstract][Full Text] [Related]
6. [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. Gélisse P; Hillaire-Buys D; Halaili E; Jean-Pastor MJ; Vespignan H; Coubes P; Crespel A Rev Neurol (Paris); 2007 Nov; 163(11):1096-9. PubMed ID: 18033049 [TBL] [Abstract][Full Text] [Related]
7. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy. Sattler A; Schaefer M; May TW Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393 [TBL] [Abstract][Full Text] [Related]
8. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine. Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Baulac M; Patten A; Giorgi L Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239 [TBL] [Abstract][Full Text] [Related]
10. Response to carbamazepine in children with newly diagnosed partial onset epilepsy. Holland KD; Glauser TA Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679 [TBL] [Abstract][Full Text] [Related]
11. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite. Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464 [TBL] [Abstract][Full Text] [Related]
12. Effect of carbamazepine therapy on serum lipids in children with partial epilepsy. Aggarwal A; Singh V; Batra S; Faridi MM; Sharma S Pediatr Neurol; 2009 Feb; 40(2):94-7. PubMed ID: 19135621 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery. Hiremath GK; Kotagal P; Bingaman W; Hovinga C; Wyllie E; Morris H; Nelson D Seizure; 2005 Jul; 14(5):312-7. PubMed ID: 15876544 [TBL] [Abstract][Full Text] [Related]
14. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study. Hur YJ Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Chadwick D Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359 [TBL] [Abstract][Full Text] [Related]
17. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857 [TBL] [Abstract][Full Text] [Related]
18. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program. Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study. Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348 [TBL] [Abstract][Full Text] [Related]
20. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. Zamponi N; Cardinali C Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]